Preparation of potent cytotoxic ribonucleases by cationization: Enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups

被引:79
作者
Futami, J [1 ]
Maeda, T [1 ]
Kitazoe, M [1 ]
Nukui, E [1 ]
Tada, H [1 ]
Seno, M [1 ]
Kosaka, M [1 ]
Yamada, H [1 ]
机构
[1] Okayama Univ, Fac Engn, Dept Biosci & Biotechnol, Okayama 7008530, Japan
关键词
D O I
10.1021/bi010248g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carboxyl groups of bovine RNase A were amidated with ethylenediamine (to convert negative charges of carboxylate anions to positive ones), 2-aminoethanol (to eliminate negative charges), and taurine (to keep negative charges), respectively, by a carbodiimide reaction. Human RNase 1 was also modified with ethylenediamine. Surprisingly, the modified RNases were all cytotoxic toward 3T3-SV-40 cells despite their decreased ribonucleolytic activity. However, their enzymatic activity was not completely eliminated by the presence of excess cytosolic RNase inhibitor (RI). As for native RNase A and RNase 1 which were not cytotoxic, they were completely inactivated by RI. More interestingly, within the cytotoxic RNase derivatives. cytotoxicity correlated well with the net positive charge. RNase 1 and RNase A modified with ethylenediamine were more cytotoxic than naturally occurring cytotoxic bovine seminal RNase. An experiment using the fluorescence-labeled RNase derivatives indicated that the more cationic RNases were more efficiently adsorbed to the cells. Thus, it is suggested that the modification of carboxyl groups could change complementarity of RNase to RI and as a result endow RNase cytotoxicity and that cationization enhances the efficiency of cellular uptake of RNase so as to strengthen its cytotoxicity. The finding that an extracellular human enzyme such as RNase 1 could be effectively internalized into the cell by cationization suggests that cationization is a simple strategy for efficient delivery of a protein into cells and may open the way of the development of new therapeutics.
引用
收藏
页码:7518 / 7524
页数:7
相关论文
共 47 条
  • [1] APPLE RJ, 1988, J IMMUNOL, V140, P3290
  • [2] Protein therapy - delivery guaranteed
    Bayley, H
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (11) : 1066 - +
  • [3] MOLECULAR EVOLUTION OF THE RIBONUCLEASE SUPERFAMILY
    BEINTEMA, JJ
    SCHULLER, C
    IRIE, M
    CARSANA, A
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1988, 51 (03) : 165 - 192
  • [4] MULTIPLE CARBOXYMETHYLATION OF HISTIDINES IN BOVINE RIBONUCLEASE-A
    BELLO, J
    NOWOSWIAT, EF
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1971, 22 (02): : 225 - +
  • [5] A ribonuclease A variant with low catalytic activity but high cytotoxicity
    Bretscher, LE
    Abel, RL
    Raines, RT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) : 9893 - 9896
  • [6] Chekhonin VP, 1995, NEUROREPORT, V7, P129, DOI 10.1097/00001756-199512290-00031
  • [7] Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins
    Deonarain, MP
    Epenetos, AA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (04) : 537 - 546
  • [8] Fitzgerald D, 1998, CURR TOP MICROBIOL, V234, P1
  • [9] Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans
    Futami, J
    Tsushima, Y
    Murato, Y
    Tada, H
    Sasaki, J
    Seno, M
    Yamada, H
    [J]. DNA AND CELL BIOLOGY, 1997, 16 (04) : 413 - 419
  • [10] RECOMBINANT HUMAN PANCREATIC RIBONUCLEASE PRODUCED IN ESCHERICHIA-COLI - IMPORTANCE OF THE AMINO-TERMINAL SEQUENCE
    FUTAMI, J
    SENO, M
    KOSAKA, M
    TADA, H
    SENO, S
    YAMADA, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (01) : 406 - 413